Krawczyk, Malgorzata Anna <br/><br/>
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.  [electronic resource] 

 -  Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals  Sep 2019 
 - 538-548 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1366-5804 
<br/><br/><label>Standard No.: </label>10.1080/1354750X.2019.1606275  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antigens, Neoplasm--genetics<br/>Biomarkers, Tumor--genetics<br/>Biopsy<br/>Carbonic Anhydrase IX--genetics<br/>Carboplatin--therapeutic use<br/>Chemotherapy, Adjuvant--methods<br/>Child<br/>Child, Preschool<br/>Dactinomycin--therapeutic use<br/>Epirubicin--therapeutic use<br/>Female<br/>Gene Expression<br/>Glucose Transporter Type 1--genetics<br/>Humans<br/>Hypoxia--diagnosis<br/>Hypoxia-Inducible Factor 1, alpha Subunit--genetics<br/>Ifosfamide--therapeutic use<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Muscle Neoplasms--diagnosis<br/>Neoadjuvant Therapy--methods<br/>Prognosis<br/>Prospective Studies<br/>Rhabdomyosarcoma, Alveolar--diagnosis<br/>Rhabdomyosarcoma, Embryonal--diagnosis<br/>Survival Analysis<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vincristine--therapeutic use